In 2021, six listed pharmacy chains completed the disclosure of their 2021 financial results. In terms of scale, DaShenLin, LBX, Yifeng, and Yixintang are at the RMB 15 billion yuan (USD $2.24 billion) level, while Shu Yu Civilian and Jianzhijia are at the RMB 5 billion yuan (USD $750 million) level. When all six companies had a revenue growth rate around 15%, the net profit was more divided, with Jianzhijia and Yifeng Pharmacy growing by 20% and 19%, and Shu Yu Civil and DaShenLin declining by 47% and 26%. Moreover, the number of stores of all six companies was increasing in 2021 where DaShenLin ranked first with 2173 new stores. (Source: shuzhengkangxun)
Visit HPA-China’s Information Hub, CLICK HERE